References
- Platanias L C, Ratain M J. Hairy cell leukaemia: The role of alpha interferon. Eur J Cancer 1991; 27: S53–57, Suppl. 4
- Vedantham S, Gamliel H, Golomb H M. Mechanisms of interferon action in hairy cell leukemia: A model of effective cancer biotherapy. Cancer Res 1992; 52: 1056–1066
- Jabbar S A, Twentyman P R. The use of clonogenic assays in assessing the response of buman lung cancer cell lines to alpha and gamma interferons alone or in combination with adriamycin. Int J Cancer 1990; 46: 546–551
- Von-Hoff D D. In vitro data supporting interferon plus cytotoxic agent combinations. Semin Oncol 1991; 18: 58–61
- Chirigos M A, Pearson J W. Cure of murine leukemia with drug and interferon treatment. J Natl Cancer Inst 1973; 51: 1367–1368
- McBee P, Petriauolo Katoh W. A. Inhibition of liver metastases in nude mice by the combined action of 5-fluorouracil and interferon. Anticancer Drugs 1990; 1: 165–170
- Harrison S D, Stevens J J, Waud W R, Dykes D J, Schmid S M, Griswold DP, Jr. Evaluation of combinations of interferons and cytotoxic drugs in murine tumour models in vivo. J Biol Respir Mod 1990; 9: 395–400
- Wadler S, Schwartz E L. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: A review. Cancer Res 1990; 50: 3473–3486
- Carte; G, Rosa Bian A, Cendron R, Collimendaglia P, Kolarich K, Della Valentina M, Veronesi A, Coletti B, Antoci B. Evaluation of synergy with cDDP in non-small cell lung cancer: interim report from a multicentric study. Proc Am Sac Clin Oncol 1988; 7: 198
- Klastersky J, Sculier J P, Bureau G, Libert P, Ravez P, Vandermoten G, Thiriaux J, Lecomte J, Cordier R, Dabouis G, Brohee D, Themelin L, Mommen P. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer. J Clin Oncol 1989; 7: 1087–1092
- Carmichael J, Fergusson R J, Wolf C R, Balkwill F R, Smyth J F. Augmentation of cytotoxicity of chemotherapy by human alpha interferons in human non-small cell lung cancer xenografts. Cancer Res 1986; 46: 4916–4920
- Bowman A, Fergusson R J, Allan S G, Stewart M E, Gregor A, Combleet M A, Greening A P, Crompton G K, Leonard R CF, Smyth F J. Potentiation of cisplatin by alpha interferon in advanced non-small cell lung cancer (NSCLC): a phase II study. Ann Oncol 1990; 1: 351–353
- Moochhala S M, Renton K W. Induction and depression of cytochrome P-450-dependent mixed-function-oxidase by a cloned consensus a-interferon (IFN-α-CON1) in the hamster. Biochem Pharmacol 1989; 38: 439–447
- Ehrsson H, Eksborg S, Wallin I, Osterborg A, Mellstedt H. Oral melphalan pharmacokinetics. Influence of interferon induced fever. Clin Pharmacol Ther 1990; 47: 86–90
- Yoneda K, Yamamoto T, Osaki T. [Enhanced cytotoxicity of antineoplastics by interferon]. Nippon Can Chiryo Gakki Shi 1990; 25: 77–84
- Martin A D, Beer R WG, Bosanquet A G, Gilby E D. The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukemia cells in vitro. Biochem Pharmacol 1982; 31: 2727–2732
- Gresser I, Maury C, Bronty-Boye D. On the mechanism of the antitumour effect of interferon in mice. Nature (Lond) 1972; 239: 167–168
- Thomassen M J, Wiedermann H P, Barna B P, Fanner M, Ahmad M. Induction of in vitro tumouricidal activity in alveolar macrophages and monocytes from patients with lung cancer. Cancer Res 1988; 48: 3949–3953
- Babich M A, Day RS, III. Synergistic killing of virus transformed human cells with interferon and N-methyl-N′-nitro-N-nitro-soguanidine. Carcinogenesis 1989; 10: 265–268
- Roberts J J, Knox R J, Friedlos F, Lydall D A. DNA as the target for the cytotoxic and antiturnour action of platinum co-ordination complexes: Comparative in vitro and in vivo studies of cisplatin and carboplatin. Biochemical Mechanisms of Platinum Antitumour Drugs, DCH McBrien, TF Slater. IRL Press, Oxford 1986; 29–64
- Vadiei K, Siddik Z H, Khokhar A R, Al-Baker S, Sampedro F, Perez-Soler R. Pharmacokinetics of liposome entrapped cis-bisneodecanoato-trans-R, R-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat. Cancer Chemother Pharmacol 1992; 30: 365–369
- Roos G, Leonderson T, Lundgren E. Interferon-induced changes in human haemopoietic cell lines and fresh leukemic cells. Cancer Res 1984; 44: 2358–2362
- Pfeffer L M, Colamonici O R. Transmembrane signalling by interferon-alpha. Pharmacol Ther 1991; 52: 149–157
- Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial function. FASEB J 1992; 6: 2591–2599